Form 6-K AerCap Holdings N.V. For: Oct 07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
| For the month of October 2026 | Commission File Number 001-33159 |
AERCAP HOLDINGS N.V.
(Translation of Registrant’s Name into English)
AerCap House, 65 St. Stephen’s Green, Dublin D02 YX20, Ireland, +353 1 819 2010
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
| Form 20-F ☒ | Form 40-F ☐ |
Other Events
On October 7, 2026, AerCap Funding Designated Activity Company (the “Issuer”), a wholly-owned subsidiary of AerCap Holdings N.V. (“AerCap”), issued $750 million aggregate principal amount of the Issuer’s 5.500% Senior Notes due 2030 (the “2030 Notes”) and $750 million aggregate principal amount of the Issuer’s 5.875% Senior Notes due 2033 (the “2033 Notes” and, together with the 2030 Notes, the “Notes”). In connection with the issuance of the Notes, AerCap is filing the following documents solely for incorporation into the Registration Statement on Form F-3 (File No. 333-297097).
Exhibits
| 5.1 | Opinion of Cravath, Swaine & Moore LLP. |
| 5.2 | Opinion of NautaDutilh N.V. |
| 5.3 | Opinion of McCann FitzGerald LLP. |
| 5.4 | Opinion of Morris, Nichols, Arsht & Tunnell LLP. |
| 5.5 | Opinion of Smith, Gambrell & Russell, LLP. |
| 23.1 | Consent of Cravath, Swaine & Moore LLP (included in Exhibit 5.1). |
| 23.2 | Consent of NautaDutilh N.V. (included in Exhibit 5.2). |
| 23.3 | Consent of McCann FitzGerald LLP (included in Exhibit 5.3). |
| 23.4 | Consent of Morris, Nichols, Arsht & Tunnell LLP (included in Exhibit 5.4). |
| 23.5 | Consent of Smith, Gambrell & Russell, LLP (included in Exhibit 5.5). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AERCAP HOLDINGS N.V. | ||||
| By: | /s/ Aengus Kelly | |||
| Name: | Aengus Kelly | |||
| Title: | Authorized Signatory | |||
Date: October 7, 2026
EXHIBIT INDEX
| 5.1 | Opinion of Cravath, Swaine & Moore LLP. |
| 5.2 | Opinion of NautaDutilh N.V. |
| 5.3 | Opinion of McCann FitzGerald LLP. |
| 5.4 | Opinion of Morris, Nichols, Arsht & Tunnell LLP. |
| 5.5 | Opinion of Smith, Gambrell & Russell, LLP. |
| 23.1 | Consent of Cravath, Swaine & Moore LLP (included in Exhibit 5.1). |
| 23.2 | Consent of NautaDutilh N.V. (included in Exhibit 5.2). |
| 23.3 | Consent of McCann FitzGerald LLP (included in Exhibit 5.3). |
| 23.4 | Consent of Morris, Nichols, Arsht & Tunnell LLP (included in Exhibit 5.4). |
| 23.5 | Consent of Smith, Gambrell & Russell, LLP (included in Exhibit 5.5). |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AerCap Holdings (AER) PT Raised to $185 at TD Cowen
- Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
- Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share